Regardless, using both genetic and pharmacologic approaches, DMP1 restoration corrects the bone mineralization defect, prevents alterations in osteocyte morphology and networks in mice with advanced CKD, and prevents osteocyte apoptosis in vivo and in vitro. This evidence concerns the gene DMP1 and chronic kidney disease.